Active
    Mainboard

    Molbio Diagnostics Ltd

    Apply Now

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    Molbio Diagnostics Ltd IPO opens on 10 Aug 2026 and closes on 12 Aug 2026, with a price band of ₹768–₹807 per share. The IPO has a lot size of 18 shares, requiring a minimum investment of ₹14,526 per lot at the upper price band. The issue size is ₹939.7 crore, and the shares are expected to list on 17 Aug 2026.

    Molbio Diagnostics Ltd IPO Details

    Listing Date

    17 Aug 2026

    Bid Price

    ₹768 - ₹807

    Lot Size

    18 Shares

    Minimum Investment

    ₹14,526 / Lot

    Issue Size

    ₹939.7 Cr

    Employee Discount

    ₹76 per share

    Key Dates to Track

        Here are the important dates you need to know in order to participate in this IPO

    tick

    Offer Start Date

    10th Aug

    tick

    Offer End Date

    12th Aug

    tick

    Allotment Date

    13th Aug

    tick

    Refund Initiation

    14th Aug

    tick

    Demat Transfer

    14th Aug

    tick

    Listing Date

    17th Aug

    Molbio Diagnostics Ltd Shareholding Pattern

      Pre-Issue Post-Issue
    Promoter Group 46.65% 39.84%
    Public Group 53.35% 60.16%

    Molbio Diagnostics Ltd IPO Reservation

    QIB Shares Offered 23,25,146 (19.97%)
    NII (HNI) Shares Offered 17,43,859 (14.98%)
    Retail Shares Offered 40,69,005 (34.94%)
    Anchor Investor Shares Offered 34,87,717 (29.95%)
    Total Shares Offered 1,16,44,314
    Total Shares With Anchor Investor 1,16,44,314

    Molbio Diagnostics Ltd IPO Lot Size

    Application Lots Shares Amount
    Retail (Min) 1 18 ₹14,526
    Retail (Max) 13 234 ₹1,88,838
    S HNI (Min) 14 252 ₹2,03,364
    S HNI (Max) 68 1,224 ₹9,87,768
    B HNI (MIN) 69 1,242 ₹10,02,294

    Molbio Diagnostics Ltd IPO Anchor Portion Size

    Bid Date August 07, 2026

    Molbio Diagnostics Ltd IPO registrar

    KFin Techologies Ltd
    Phone Number +91 40 6716 2222
    Email Id molbio.ipo@kfintech.com
    Website www.kfintech.com

    Molbio Diagnostics Ltd IPO Lead Manager

    1. Kotak Mahindra Capital Company Limited

    2. IIFL Capital Services Limited

    3. Jefferies India Private Limited

    4. Motilal Oswal Investment Advisors Limited

    Molbio Diagnostics Ltd Financial Information

    March 31, 2025 March 31, 2024 March 31, 2023
    Net Worth ₹968.39 Cr ₹823.38 Cr ₹721.48 Cr
    Reserves and Surplus ₹966.14 Cr ₹821.13 Cr ₹719.22 Cr
    Total Borrowing ₹123.16 Cr ₹174.58 Cr ₹108.44 Cr

    Strength of Molbio Diagnostics Ltd

    • We are well placed to address unmet demand in a large and growing molecular diagnostic market with gaining credence of point-of-care testing.
    • Innovative, R&D focussed business.
    • We have developed and commercialized a novel portable multi-disease point-of-care molecular diagnostics platform.
    • We have a scalable business model with strong entry barriers, high proportion of recurring revenues and a growing suite of tests.
    • Our strategic collaborations and acquisitions enhance our capabilities and offerings.
    • We have a management team with deep domain expertise and track record of delivering strong financial performance.

    Risks Involved

    • We derive a portion of our revenues from the sale of our products to the Indian central and state governments, and international aid agencies for their public healthcare programs. Our revenue from such government and international aid agencies was 84.56%, 87.83% and 91.60% of our revenue from contracts with customers - sale of products - finished goods in Fiscals 2026, 2025 and 2024, respectively. Any unfavourable policy changes by these agencies or a decrease in funding for public healthcare programs may impact the sale of our products and adversely affect our business, financial condition, results of operations and cash flows. Further, our revenue from the top 10 customers was 83.26%, 83.62% and 78.54% of our revenue from contracts with customers - sale of products - finished goods in Fiscals 2026, 2025 and 2024, respectively. The loss of any of these customers or a decline in demand for our products from them could also have an adverse effect on our business, financial condition, results of operations and cash flows.
    • We derive a portion of our revenues from the sale of diagnostic test kits for tuberculosis ("TB"). Our revenue from the sale of test kits for TB was 70.20%, 69.11% and 62.40% of our revenue from contracts with customers - sale of products - finished goods in the Fiscals 2026, 2025 and 2024, respectively. Any decline in the demand for such test kits may have an adverse effect on our business, financial condition, results of operation and cash flows.
    • We have invested and intend to continue to invest in research and development ("R&D") efforts to grow our menu of tests. We cannot assure you that our R&D efforts will result in the successful development and obtaining of government approvals for new tests, which could adversely affect our business, results of operations, and cash flows.
    • Our Subsidiaries, Prognosys Medical Systems Private Limited, Prognosys Healthcare (India) Private Limited and OptraScan INC, have incurred losses in the past and may incur losses in the future which could have an adverse effect on our business, financial condition, results of operations and cash flows. Further, our Company (on a consolidated basis) and some of our Subsidiaries have experienced negative cash flows from operating activities in the past. Any such negative cash flows in the future could affect our business, results of operations, financial condition and cash flows.
    • Our Promoters (certain of whom are also Directors) hold Equity Shares in our Company and may be interested in our Company's performance in addition to any remuneration and reimbursement of expenses payable to them.
    • If we are unable to patent new processes and protect our proprietary information or other intellectual property, our business may be adversely affected.
    • Our Statutory Auditors' audit reports on our audited consolidated financial statements for Fiscals 2026, 2025 and 2024 includes emphasis of matter paragraph, modifications for certain matters specified in the report on other legal and regulatory requirements and certain qualifications under the reporting requirements under the Companies (Auditor's Report) Order, 2020 and Rule 11(g) of the Companies (Audit and Auditors) Rules, 2014 (as amended). We cannot assure you that auditors' reports for any future fiscal periods will not contain such emphasis of matter, modifications, qualifications and observations.
    • We intend to utilize a portion of the Net Proceeds for funding our capital expenditure requirements towards (i) the setting up of infrastructure for a research and development facility and Center of Excellence which will be operated by our wholly-owned Subsidiary, Bigtec, and connected office space for our Company, Subsidiaries and Associate, and (ii) purchase of certain plant, machinery and other equipment for Goa Unit I, Goa Unit II and Visakhapatnam Unit. Our inability to successfully undertake such capital expenditure within the estimated cost could have a material adverse effect on our business, cash flows, operations, prospects or financial results.
    • Any product liability claims or regulatory actions or imposition of liquidated damages on account of our failure to meet the contractual obligations, could have an adverse effect on our business, results of operations, financial condition and cash flows.
    • There have been certain instances of delays in payment of statutory dues by us in the past. Any delay in payment of statutory dues by us in future, may result in the imposition of penalties and in turn may have an adverse effect on our business, financial condition, results of operation and cash flows.
    Invest in IPOs with ease

    Sign-in to invest with your demat account, or set up a new demat account for free

    Explore Other IPOs

    • Current IPOs
    • Upcoming IPOs
    • Closed IPOs
    • IPO Performance
    • All
    • MainBoard
    • SME
    LEAP INDIA LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    7th Aug 2026 - 8th Aug 2026
    Price Range
    ₹151.0 - 159.0
    IPO Size
    ₹24,80,00,00,000
    Bidding Period
    7th Aug 2026 - 8th Aug 2026
    Price Range
    ₹166.0 - 175.0
    IPO Size
    ₹1,08,49,99,936
    TECHNOCRAFT VENTURES LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    7th Aug 2026 - 8th Aug 2026
    Price Range
    ₹200.0 - 212.0
    IPO Size
    ₹2,51,88,00,128
    DHOOT TRANSMISSION LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    10th Aug 2026 - 8th Aug 2026
    Price Range
    ₹829.0 - 871.0
    IPO Size
    ₹30,66,88,98,304
    MOLBIO DIAGNOSTICS LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    10th Aug 2026 - 8th Aug 2026
    Price Range
    ₹768.0 - 807.0
    IPO Size
    ₹9,39,70,00,192
    Bidding Period
    11th Aug 2026 - 8th Aug 2026
    Price Range
    ₹133.0 - 140.0
    IPO Size
    ₹15,53,00,00,384
    LAPL AUTOMOTIVE LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    6th Aug 2026 - 8th Aug 2026
    Price Range
    ₹88.0 - 94.0
    IPO Size
    ₹32,40,00,000
    • All
    • MainBoard
    • SME
    Fascinate Textiles Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    11th Aug 2026 - 8th Aug 2026
    Price Range
    ₹148.0 - 156.0
    IPO Size
    ₹66,98,00,064
    Sham Foam Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    11th Aug 2026 - 8th Aug 2026
    Price Range
    ₹130.0 - 130.0
    IPO Size
    ₹0
    Bidding Period
    12th Aug 2026 - 8th Aug 2026
    Price Range
    ₹271.0 - 285.0
    IPO Size
    ₹0
    Pramodini Medicare Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    12th Aug 2026 - 8th Aug 2026
    Price Range
    ₹110.0 - 118.0
    IPO Size
    ₹69,04,00,000
    Shiprocket Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    12th Aug 2026 - 8th Aug 2026
    Price Range
    ₹92.0 - 97.0
    IPO Size
    ₹16,17,49,00,224
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    AceVector Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    Advanced SysTek Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    Advanta Enterprises Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    Agilus Diagnostics Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    Airox Technologies Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    Ajay Poly Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    Allchem Lifescience Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    Annu Projects Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    AOne Steels India Limited IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    To Be Announced
    Price Range
    ₹0.0 - 0.0
    IPO Size
    ₹0
    NO ACTIVE IPO HERE
    • All
    • MainBoard
    • SME
    G V ELECTRICALS LIMITED IPO
    icon
    Closing Today
    SME IPO
    Early Access
    Bidding Period
    31st Jul 2026 - 8th Aug 2026
    Price Range
    ₹123.0 - 130.0
    IPO Size
    ₹42,25,00,000
    ARDEE INDUSTRIES LIMITED IPO
    icon
    Closing Today
    SME IPO
    Early Access
    Bidding Period
    5th Aug 2026 - 8th Aug 2026
    Price Range
    ₹50.0 - 53.0
    IPO Size
    ₹4,25,87,00,032
    AEGEUS TECHNOLOGIES LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    4th Aug 2026 - 8th Aug 2026
    Price Range
    ₹100.0 - 105.0
    IPO Size
    ₹23,70,99,984
    Bidding Period
    3rd Aug 2026 - 8th Aug 2026
    Price Range
    ₹257.0 - 270.0
    IPO Size
    ₹1,77,80,99,968
    Bidding Period
    31st Jul 2026 - 8th Aug 2026
    Price Range
    ₹151.0 - 159.0
    IPO Size
    ₹39,04,00,000
    DHAVAL PACKAGING LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    30th Jul 2026 - 8th Aug 2026
    Price Range
    ₹92.0 - 97.0
    IPO Size
    ₹36,36,00,000
    JUNIPER GREEN ENERGY LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    30th Jul 2026 - 8th Aug 2026
    Price Range
    ₹214.0 - 225.0
    IPO Size
    ₹17,99,99,98,976
    MV ELECTROSYSTEMS LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    30th Jul 2026 - 8th Aug 2026
    Price Range
    ₹400.0 - 425.0
    IPO Size
    ₹2,90,00,00,000
    Bidding Period
    30th Jul 2026 - 8th Aug 2026
    Price Range
    ₹91.0 - 96.0
    IPO Size
    ₹27,65,00,000
    Bidding Period
    29th Jul 2026 - 7th Jul 2026
    Price Range
    ₹560.0 - 590.0
    IPO Size
    ₹92,75,21,99,680
    H R HYGIENE PRODUCTS LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    29th Jul 2026 - 7th Jul 2026
    Price Range
    ₹83.0 - 88.0
    IPO Size
    ₹53,95,00,032
    Bidding Period
    28th Jul 2026 - 7th Jul 2026
    Price Range
    ₹285.0 - 301.0
    IPO Size
    ₹1,59,83,00,032
    Bidding Period
    27th Jul 2026 - 7th Jul 2026
    Price Range
    ₹65.0 - 69.0
    IPO Size
    ₹28,57,00,000
    ADVANCE TECHNOFORGE LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    27th Jul 2026 - 7th Jul 2026
    Price Range
    ₹95.0 - 95.0
    IPO Size
    ₹24,03,00,000
    Bidding Period
    24th Jul 2026 - 7th Jul 2026
    Price Range
    ₹123.0 - 133.0
    IPO Size
    ₹82,43,00,032
    LOHIA CORP LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    23rd Jul 2026 - 7th Jul 2026
    Price Range
    ₹404.0 - 425.0
    IPO Size
    ₹11,01,29,00,864
    INDOMIM LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    23rd Jul 2026 - 7th Jul 2026
    Price Range
    ₹461.0 - 485.0
    IPO Size
    ₹38,12,12,01,664
    XTRANET TECHNOLOGIES LIMITED IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    23rd Jul 2026 - 7th Jul 2026
    Price Range
    ₹120.0 - 127.0
    IPO Size
    ₹1,66,80,00,000
    CUBE HIGHWAYS TRUST IPO
    icon
    SME IPO
    Early Access
    Bidding Period
    22nd Jul 2026 - 7th Jul 2026
    Price Range
    ₹151.0 - 152.0
    IPO Size
    ₹49,99,99,98,976
    Bidding Period
    22nd Jul 2026 - 7th Jul 2026
    Price Range
    ₹66.0 - 70.0
    IPO Size
    ₹18,90,00,000
    • All
    • MainBoard
    • SME
    DHAVAL PACKAGING LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    97.00
    Listing Day Close
    111.68(15.46%)
    JUNIPER GREEN ENERGY LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    225.00
    Listing Day Close
    259.60(15.56%)
    MV ELECTROSYSTEMS LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    425.00
    Listing Day Close
    622.75(46.59%)
    Issue Prize
    96.00
    Listing Day Close
    126.00(31.25%)
    Issue Prize
    590.00
    Listing Day Close
    666.70(13.05%)
    H R HYGIENE PRODUCTS LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    88.00
    Listing Day Close
    87.97(0.00%)
    Issue Prize
    301.00
    Listing Day Close
    493.50(64.12%)
    Issue Prize
    69.00
    Listing Day Close
    57.15(-17.39%)
    ADVANCE TECHNOFORGE LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    95.00
    Listing Day Close
    89.30(-6.32%)
    Issue Prize
    133.00
    Listing Day Close
    126.55(-4.51%)
    LOHIA CORP LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    425.00
    Listing Day Close
    494.65(16.47%)
    INDOMIM LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    485.00
    Listing Day Close
    741.80(52.99%)
    XTRANET TECHNOLOGIES LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    127.00
    Listing Day Close
    124.80(-1.57%)
    CUBE HIGHWAYS TRUST IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    152.00
    Listing Day Close
    156.88(3.29%)
    Issue Prize
    70.00
    Listing Day Close
    126.35(80.00%)
    METALIC TECHNOFORGE LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    77.00
    Listing Day Close
    83.05(7.79%)
    GULF LLOYDS INDIA LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    100.00
    Listing Day Close
    95.00(-5.00%)
    Issue Prize
    424.00
    Listing Day Close
    528.50(24.76%)
    SOTEFIN BHARAT LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    187.00
    Listing Day Close
    215.25(14.97%)
    ALPINE TEXWORLD LIMITED IPO
    icon
    SME IPO
    Early Access
    Issue Prize
    105.00
    Listing Day Close
    99.75(-4.76%)

    Frequently Asked Questions

    What is Molbio Diagnostics Ltd IPO?

    Answer Field

    Molbio Diagnostics Ltd IPO is a Mainboard IPO of 1,16,44,314 equity shares of a face value of ₹1 aggregating up to ₹939.7 Crores. The issue is priced at ₹768 to ₹807 per share. The minimum order quantity is 18 Shares. The IPO opens on August 10, 2026, and closes on August 12, 2026. KFin Techologies Ltd is the registrar for the IPO. The shares are proposed to be listed on BSE,NSE.

    When Molbio Diagnostics Ltd IPO will open?

    Answer Field

    The Molbio Diagnostics Ltd IPO opens on August 10, 2026 and closes on August 12, 2026.

    What is the lot size of Molbio Diagnostics Ltd?

    Answer Field

    Molbio Diagnostics Ltd lot size is 18 shares, and the minimum amount required is ₹14,526.

    How to apply for Molbio Diagnostics Ltd IPO?

    Answer Field

    You can apply in Molbio Diagnostics Ltd IPO online using either UPI or ASBA as payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don't offer banking services. To apply for an IPO:

    • Login to Bajaj Broking account App/Website & click on IPO
    • Enter the number of lots and price at which you wish to apply.
    • Enter your UPI ID and click on submit. With this, your bid will be placed with the exchange.
    • You will receive a mandate notification to block funds in your UPI app.
    • Approve the mandate request on your UPI and funds will be blocked.

    When is Molbio Diagnostics Ltd IPO allotment?

    Answer Field

    The finalization of Basis of Allotment for Molbio Diagnostics Ltd IPO will be done on August 13, 2026, and the allotted shares will be credited to your demat account by August 14, 2026.

    When is Molbio Diagnostics Ltd IPO listing date?

    Answer Field

    The Molbio Diagnostics Ltd listing date is August 17, 2026.

    Who is the registrar of Molbio Diagnostics Ltd IPO?

    Answer Field

    The registrar of Molbio Diagnostics Ltd IPO is KFin Techologies Ltd

    Which company is the book-running lead manager of the IPO?

    Answer Field

    Kotak Mahindra Capital Company Limited,IIFL Capital Services Limited,Jefferies India Private Limited,Motilal Oswal Investment Advisors Limited will be the book-running lead manager of this IPO.

    What is the fresh issue of Molbio Diagnostics Ltd IPO?

    Answer Field

    The fresh issue size is ₹200 Crores equity shares.

    What minimum lot size can retail subscribers subscribe to Molbio Diagnostics Ltd?

    Answer Field

    Retail investors can subscribe to a minimum of one lot, 18 shares and ₹14,526 amount.

    How can I approve the UPI mandate request for Molbio Diagnostics Ltd IPO?

    Answer Field

    To apply for Molbio Diagnostics Ltd IPO, you need to log in to your demat account to complete the bidding process. Then, approve the payment mandate on your UPI app.

    What is the price range of Molbio Diagnostics Ltd?

    Answer Field

    The price of each Molbio Diagnostics Ltd share will be ranging in between ₹768 to ₹807 per share.

    What is the cut-off time for the UPI mandate for Molbio Diagnostics Ltd IPO?

    Answer Field

    The cut-off time for the UPI mandate confirmation is 5:00 PM, August 12, 2026.

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |